SeaStar Medical is trading 5.1% down now at $2.96 after broader risk-off sentiment pressured U.S. equities on September 1, 2026.

  • Rising oil prices, Middle East tensions, higher bond yields, and increased rate-hike concerns weighed on stocks globally, according to Reuters.
  • No September 1 company-specific announcement was identified; SeaStar Medical’s latest listed release concerned its August 12, 2026 results and business updates.